Issue Date | Title | Author(s) |
Dec-2019 | Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model | Armin Mooranian; Nassim Zamani; Giuseppe Luna; Hesham Al-Sallami; Momir Mikov ; Svetlana Goločorbin-Kon ; Goran Stojanović ; Frank Arfuso; Božica Kovačević; Hani Al-Salami |
2019 | Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide | Gedawy, Ahmed; Al-Salami, Hani; Dass, Crispin R. |
Feb-2020 | DPP-4 Inhibitors: Renoprotective Potential and Pharmacokinetics in Type 2 Diabetes Mellitus Patients with Renal Impairment | Momir Mikov ; Nebojša Pavlović ; Bojan Stanimirov ; Maja Đanić ; Svetlana Goločorbin-Kon ; Karmen Stankov ; Hani Al-Salami |
17-Sep-2019 | Potentials of human bile acids and their salts in pharmaceutical nano delivery and formulations adjuvants | Kecman, S; Škrbić R.; Alma Badnjević Čengić; Armin Mooranian; Hani Al-Salami; Momir Mikov ; Svetlana Goločorbin-Kon |
2019 | Semisynthetic bile acids: a new therapeutic option for metabolic syndrome | Lazarević, Slavica; Đanić, Maja ; Goločorbin-Kon, Svetlana ; Al-Salami, Hani; Mikov, Momir |
2019 | Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model | Maja Đanić ; Bojan Stanimirov ; Nebojša Pavlović ; Saša Vukmirović ; Jelena Lazić; Hani Al-Salami; Momir Mikov |